CytoDyn (CYDY) Enterprise Value (2010 - 2026)
CytoDyn (CYDY) recorded Enterprise Value of $400.2 million in fiscal Q4 2026 (quarter ended May 31, 2026), down 3.1% from $412.82 million a year earlier but up 23.6% from the prior quarter.
Powered by 
Analysis
CytoDyn (CYDY) Enterprise Value (2010 - 2026) Analysis & Trends
Starting with fiscal Q1 2011, CytoDyn's Enterprise Value history includes 64 quarters.
- Annual Enterprise Value has a five-year compound annual growth rate of -19.1% (FY2021 to FY2026).
- Across earlier fiscal years, Enterprise Value came in at $412.82 million in FY2025 (+148.3%), $166.26 million in FY2024 (-29.6%), $236.3 million in FY2023 (+4.5%) and $226.04 million in FY2022 (-80.4%).
- Quarterly Enterprise Value has ranged from $113.2 million in fiscal Q2 2025 to $881.74 million in fiscal Q1 2022 over the past five years.
- On a year-over-year basis, Enterprise Value rose in four of the last eight quarters, with growth averaging 65.5%.
- Peak year-over-year performance for Enterprise Value in the last five years was growth of 264.6% in fiscal Q2 2026, against a decline of 86.8% in fiscal Q3 2022 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $323.83 million (Q3 2026), $412.75 million (Q2 2026) and $367.7 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | CytoDyn | 288.44 Mn | 288.44 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | 400.20 Mn |
| Feb 28, 2026 | 323.83 Mn |
| Nov 30, 2025 | 412.75 Mn |
| Aug 31, 2025 | 367.70 Mn |
| May 31, 2025 | 412.82 Mn |
| Feb 28, 2025 | 365.61 Mn |
| Nov 30, 2024 | 113.20 Mn |
| Aug 31, 2024 | 158.06 Mn |
| May 31, 2024 | 166.26 Mn |
| Feb 29, 2024 | 255.98 Mn |
| Nov 30, 2023 | 164.97 Mn |
| Aug 31, 2023 | 193.47 Mn |
| May 31, 2023 | 236.30 Mn |
| Feb 28, 2023 | 262.60 Mn |
| Nov 30, 2022 | 294.54 Mn |
| Aug 31, 2022 | 417.70 Mn |
| May 31, 2022 | 226.04 Mn |
| Feb 28, 2022 | 362.41 Mn |
| Nov 30, 2021 | 847.90 Mn |
| Aug 31, 2021 | 881.74 Mn |
API Access
CytoDyn Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=CYDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "CYDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=CYDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();